Valuation: Qiagen NV

Market Cap 10.39B 9.27B 8.57B 7.76B 14.53B 986B 14.77B 103B 40.82B 517B 38.98B 38.15B 1,629B P/E 2026 *
26x
P/E 2027 * 22.8x
Enterprise Value 11.05B 9.87B 9.12B 8.26B 15.46B 1,049B 15.71B 110B 43.43B 550B 41.47B 40.59B 1,733B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.77x
Free-Float
99.37%
Yield 2026 *
0.21%
Yield 2027 * 0.32%
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2026
Director of Finance/CFO 58 01/01/2004
Chief Operating Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 77 01/06/2011
Director/Board Member 60 08/01/2021
Director/Board Member 72 23/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-4.05% - - 10.39B
+2.41%-6.33%+43.43%+71.02% 63.29B
-0.15%+3.11%+10.29%+72.56% 54.89B
+0.57%+4.64%+12.82%+89.79% 53.28B
+0.37%+3.07%+28.23%+51.53% 45.81B
-1.21%+0.95%+20.44%+128.58% 43.46B
-0.37%-1.20%+252.94%+568.54% 40.23B
+0.05%+6.75%+14.48%+56.75% 33.45B
+1.19%-5.84%+27.86%-0.65% 23.7B
-0.38%+4.55%+37.71%+28.10% 23.76B
Average +0.02%+0.22%+49.80%+118.47% 42.43B
Weighted average by Cap. +0.31%+0.50%+48.17%+122.11%

Financials

2026 *2027 *
Net sales 2.14B 1.91B 1.76B 1.6B 2.99B 203B 3.04B 21.2B 8.39B 106B 8.02B 7.85B 335B 2.24B 2B 1.85B 1.68B 3.14B 213B 3.19B 22.26B 8.81B 112B 8.42B 8.24B 352B
Net income 419M 374M 345M 313M 586M 39.75B 595M 4.16B 1.65B 20.82B 1.57B 1.54B 65.65B 485M 434M 400M 363M 679M 46.08B 690M 4.82B 1.91B 24.14B 1.82B 1.78B 76.12B
Net Debt 665M 594M 549M 497M 930M 63.15B 946M 6.6B 2.61B 33.09B 2.5B 2.44B 104B 307M 274M 253M 229M 429M 29.13B 436M 3.05B 1.21B 15.26B 1.15B 1.13B 48.12B
Logo Qiagen NV
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2025, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.1%), the United States (47.8%), Americas (4.2%) and other (13.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Qiagen NV